том 53 издание 1 страницы 37-58

Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

Тип публикацииJournal Article
Дата публикации2013-01-06
scimago Q1
wos Q1
БС1
SJR4.029
CiteScore27.4
Impact factor13.1
ISSN03621642, 15454304
Pharmacology
Toxicology
Краткое описание

The presence of epoxyeicosatrienoic acids (EETs) in tissues and their metabolism by soluble epoxide hydrolase (sEH) to 1,2-diols were first reported 30 years ago. However, appreciation of their importance in cell biology and physiology has greatly accelerated over the past decade with the discovery of metabolically stable inhibitors of sEH, the commercial availability of EETs, and the development of analytical methods for the quantification of EETs and their diols. Numerous roles of EETs in regulatory biology now are clear, and the value of sEH inhibition in various animal models of disease has been demonstrated. Here, we review these results and discuss how the pharmacological stabilization of EETs and other natural epoxy-fatty acids could lead to possible disease therapies.

Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

2
4
6
8
10
12
14
16
18
Prostaglandins and Other Lipid Mediators
18 публикаций, 3.7%
International Journal of Molecular Sciences
14 публикаций, 2.88%
Frontiers in Pharmacology
14 публикаций, 2.88%
PLoS ONE
14 публикаций, 2.88%
Journal of Medicinal Chemistry
13 публикаций, 2.67%
Proceedings of the National Academy of Sciences of the United States of America
11 публикаций, 2.26%
Scientific Reports
7 публикаций, 1.44%
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
6 публикаций, 1.23%
Bioorganic and Medicinal Chemistry
6 публикаций, 1.23%
European Journal of Medicinal Chemistry
5 публикаций, 1.03%
Bioorganic and Medicinal Chemistry Letters
5 публикаций, 1.03%
Toxicology and Applied Pharmacology
5 публикаций, 1.03%
Journal of Lipid Research
5 публикаций, 1.03%
FASEB Journal
5 публикаций, 1.03%
Drug Metabolism and Disposition
4 публикации, 0.82%
Molecules
4 публикации, 0.82%
Pharmacology and Therapeutics
4 публикации, 0.82%
Life Sciences
4 публикации, 0.82%
Journal of Biological Chemistry
4 публикации, 0.82%
Biochemical Pharmacology
4 публикации, 0.82%
Advances in Pharmacology
4 публикации, 0.82%
Drug Metabolism Reviews
4 публикации, 0.82%
American Journal of Physiology - Heart and Circulatory Physiology
4 публикации, 0.82%
Cells
3 публикации, 0.62%
ACS Chemical Biology
3 публикации, 0.62%
Biochemical and Biophysical Research Communications
3 публикации, 0.62%
Journal of Advanced Research
3 публикации, 0.62%
Bioorganic Chemistry
3 публикации, 0.62%
Prostaglandins Leukotrienes and Essential Fatty Acids
3 публикации, 0.62%
2
4
6
8
10
12
14
16
18

Издатели

20
40
60
80
100
120
140
160
180
Elsevier
162 публикации, 33.33%
Springer Nature
51 публикация, 10.49%
Wiley
37 публикаций, 7.61%
American Chemical Society (ACS)
34 публикации, 7%
MDPI
33 публикации, 6.79%
Frontiers Media S.A.
30 публикаций, 6.17%
Public Library of Science (PLoS)
14 публикаций, 2.88%
Taylor & Francis
13 публикаций, 2.67%
Cold Spring Harbor Laboratory
12 публикаций, 2.47%
Proceedings of the National Academy of Sciences (PNAS)
11 публикаций, 2.26%
American Society for Pharmacology and Experimental Therapeutics
7 публикаций, 1.44%
American Society for Biochemistry and Molecular Biology
7 публикаций, 1.44%
Royal Society of Chemistry (RSC)
5 публикаций, 1.03%
American Physiological Society
5 публикаций, 1.03%
Ovid Technologies (Wolters Kluwer Health)
4 публикации, 0.82%
Federation of American Societies for Experimental Biology (FASEB)
4 публикации, 0.82%
Oxford University Press
4 публикации, 0.82%
Annual Reviews
3 публикации, 0.62%
American Thoracic Society
2 публикации, 0.41%
Bentham Science Publishers Ltd.
2 публикации, 0.41%
Mary Ann Liebert
2 публикации, 0.41%
SAGE
2 публикации, 0.41%
American Society for Nutrition
2 публикации, 0.41%
Hindawi Limited
2 публикации, 0.41%
American Association for Cancer Research (AACR)
2 публикации, 0.41%
Society for Neuroscience
2 публикации, 0.41%
American Society for Clinical Investigation
1 публикация, 0.21%
CSIRO Publishing
1 публикация, 0.21%
Canadian Science Publishing
1 публикация, 0.21%
20
40
60
80
100
120
140
160
180
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
486
Поделиться
Цитировать
ГОСТ |
Цитировать
Morisseau C., Hammock B. D. Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health // Annual Review of Pharmacology and Toxicology. 2013. Vol. 53. No. 1. pp. 37-58.
ГОСТ со всеми авторами (до 50) Скопировать
Morisseau C., Hammock B. D. Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health // Annual Review of Pharmacology and Toxicology. 2013. Vol. 53. No. 1. pp. 37-58.
RIS |
Цитировать
TY - JOUR
DO - 10.1146/annurev-pharmtox-011112-140244
UR - https://doi.org/10.1146/annurev-pharmtox-011112-140244
TI - Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
T2 - Annual Review of Pharmacology and Toxicology
AU - Morisseau, Christophe
AU - Hammock, Bruce D.
PY - 2013
DA - 2013/01/06
PB - Annual Reviews
SP - 37-58
IS - 1
VL - 53
PMID - 23020295
SN - 0362-1642
SN - 1545-4304
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2013_Morisseau,
author = {Christophe Morisseau and Bruce D. Hammock},
title = {Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health},
journal = {Annual Review of Pharmacology and Toxicology},
year = {2013},
volume = {53},
publisher = {Annual Reviews},
month = {jan},
url = {https://doi.org/10.1146/annurev-pharmtox-011112-140244},
number = {1},
pages = {37--58},
doi = {10.1146/annurev-pharmtox-011112-140244}
}
MLA
Цитировать
Morisseau, Christophe, and Bruce D. Hammock. “Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health.” Annual Review of Pharmacology and Toxicology, vol. 53, no. 1, Jan. 2013, pp. 37-58. https://doi.org/10.1146/annurev-pharmtox-011112-140244.